CellaVision AB

CellaVision AB

CEVI · ST · Healthcare / Medical Devices

203.50SEK+1.50 (+0.74%)

Price History

Full chart

Market Stats

Previous Close202.00
Open200.50
Day Range200.50 – 206.00
52-Week Range117.39 – 188.02
Volume23.34K
Market Cap4.02B
P/E (TTM)31.16
Forward P/E23.81
EPS5.41
Dividend Yield1.60%
Beta0.98
50-Day Avg159.39
200-Day Avg147.15

About

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and CellaVision DM9600 to automate and simplify the process of performing blood and body fluid differentials. In addition, the company's CellaVision Bone Marrow Aspirate Application enables laboratories to automate, standardize, and simplify morphological examination of bone marrow aspirate samples; CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas, a library of blood cell images and descriptions created by digital cell morphology experts; CellaVision Review Software removes restrictive constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Steve Ferguson
  • Employees251
  • HeadquartersMobilvAegen 12, Lund, Sweden, 223 62, Sweden
  • Websitehttps://www.cellavision.com

Leadership

  • Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.Founder & Director · b. 1965
  • Mr. Steve FergusonChief Executive Officer
  • Ms. Monica JonssonChief Financial Officer · b. 1980
  • Mr. Julien VeyssyVice President of Operations · b. 1983
  • Mr. Peter WilsonVice President of Business Development & Global Marketing · b. 1967
  • Mr. Urban StrindlovVice President of Global Sales · b. 1964
  • Ms. Anne Safstrom LannerVice President of Human Resources · b. 1969
  • Ms. Helena RaihleCorporate Communications & Investor Relations
  • Lisa Bodily NordqvistCorporate Communications & Investor Relations

Financials

Income Statement

Currency: SEK2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-8.04M13.67M14.97M29.84M39.02M54.78M74.56M100.44M108.97M131.64M155.40M169.51M179.85M216.92M239.39M265.04M309.31M364.81M461.77M471.44M565.55M639.34M677.29M723.22M758.97M
Growth (%)--+69.95%+9.55%+99.30%+30.74%+40.39%+36.12%+34.71%+8.49%+20.80%+18.05%+9.08%+6.10%+20.61%+10.36%+10.71%+16.70%+17.94%+26.58%+2.09%+19.96%+13.05%+5.94%+6.78%+4.94%
Cost of Revenue-1.53M2.06M3.23M10.21M13.98M21.05M29.31M36.94M32.49M44.08M53.99M59.46M67.22M71.81M65.16M76.10M86.09M93.95M125.04M158.40M173.25M201.02M214.25M236.14M239.09M
Gross Profit-------45.25M63.50M76.49M87.56M101.41M110.06M112.63M145.10M174.23M188.94M223.22M270.87M336.73M313.04M392.30M438.32M463.04M487.07M519.88M
Gross Margin-------60.69%63.22%70.19%66.51%65.26%64.93%62.62%66.89%72.78%71.29%72.17%74.25%72.92%66.40%69.37%68.56%68.37%67.35%68.50%
Operating Expense-------42.11M50.12M61.71M73.61M83.61M89.35M86.68M102.29M108.76M114.77M132.33M159.26M210.16M202.77M229.57M280.05M295.99M309.39M317.80M
Operating Income-------3.14M13.38M14.78M13.95M17.80M20.70M25.95M42.81M65.47M74.17M90.89M111.61M126.58M110.27M162.73M158.27M167.05M177.68M202.07M
Operating Margin-------4.21%13.32%13.56%10.60%11.45%12.21%14.43%19.74%27.35%27.98%29.39%30.59%27.41%23.39%28.77%24.75%24.66%24.57%26.62%
EBITDA-------3.40M13.75M14.78M20.09M25.34M26.68M27.05M44.25M73.13M75.48M98.79M113.83M150.87M134.37M193.60M190.87M207.25M219.75M237.28M
EBITDA Margin-------4.56%13.69%13.56%15.26%16.31%15.74%15.04%20.40%30.55%28.48%31.94%31.20%32.67%28.50%34.23%29.85%30.60%30.39%31.26%
Net Income-------2.63M25.05M27.72M38.35M14.63M6.45M18.93M31.46M52.82M59.80M69.72M88.69M99.17M89.48M125.34M118.33M130.31M140.72M153.08M
Net Income Margin-------3.52%24.94%25.44%29.13%9.42%3.81%10.53%14.51%22.07%22.56%22.54%24.31%21.48%18.98%22.16%18.51%19.24%19.46%20.17%
R&D-21.85M20.79M16.09M14.30M11.47M14.36M11.14M11.90M12.06M17.34M21.41M21.43M20.68M22.77M27.12M29.24M26.79M39.25M56.42M51.25M64.25M88.55M83.33M87.45M97.58M
R&D as % of Total Revenue-271.62%152.11%107.48%47.93%29.40%26.22%14.94%11.85%11.07%13.17%13.78%12.65%11.50%10.49%11.33%11.03%8.66%10.76%12.22%10.87%11.36%13.85%12.30%12.09%12.86%
Interest Expense0000000777.00K693.00K631.00K3.23M399.00K517.00K323.00K534.00K10.00K37.00K158.00K159.00K1.50M2.55M1.87M2.34M3.26M8.16M10.71M
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.00%0.00%0.00%1.04%0.69%0.58%2.45%0.26%0.30%0.18%0.25%0.00%0.01%0.05%0.04%0.32%0.54%0.33%0.37%0.48%1.13%1.41%

Balance Sheet

Currency: SEK2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets84.89M115.35M73.69M30.53M45.12M46.24M41.33M44.12M96.47M113.35M162.50M178.73M178.56M188.57M202.25M220.43M256.44M300.60M372.78M641.71M668.02M825.21M891.75M928.71M1.01B1.09B
Total Liabilities18.21M32.74M25.02M22.46M26.97M19.68M23.60M24.05M50.49M38.55M49.08M52.66M53.64M56.06M50.95M36.91M50.27M59.75M82.41M293.34M238.41M281.93M250.12M212.32M196.16M207.31M
Total Equity66.67M82.60M48.66M8.07M18.15M26.56M17.73M20.07M45.98M74.80M113.42M126.07M124.91M132.52M151.30M183.52M206.18M240.85M290.38M348.37M429.62M543.28M641.63M716.39M815.73M887.58M
Cash60.68M49.65M39.24M5.07M19.16M17.59M16.75M16.35M19.64M21.96M35.81M56.82M46.24M57.88M51.91M106.69M132.45M154.55M169.06M102.31M102.26M130.29M108.05M121.64M149.43M188.22M
Total Debt-------9.43M22.79M16.62M35.83M18.92M14.27M19.98M-1.14M5.05M1.63M4.83M173.69M132.78M136.65M102.50M64.70M26.85M25.65M
Net Debt--------6.91M3.15M-5.35M21.00K-37.90M-31.96M-37.90M-51.91M-105.56M-127.40M-152.91M-164.22M71.38M30.52M6.37M-5.56M-56.94M-122.58M-162.56M

Cash Flow

Currency: SEK2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow------950.00K6.67M1.27M20.58M11.46M32.02M11.49M27.27M39.78M88.00M76.57M87.90M74.07M125.99M71.12M159.72M137.28M196.44M198.44M200.53M
Investing Cash Flow----642.00K---7.37M-11.33M-11.11M-4.79M-5.89M-11.09M-11.79M-13.86M-9.36M-15.03M-29.69M-23.86M-266.30M-34.96M-84.34M-70.01M-85.53M-76.01M-86.16M
Financing Cash Flow79.81M54.57M34.28M-38.05M15.36M-295.00K13.35M-7.14M7.17M-5.12M-10.99M-3.83M-31.90M-23.85M-35.78M-35.78M-35.78M72.98M-35.22M-48.48M-90.41M-97.04M-95.09M-74.59M
Capital Expenditure1.12M3.28M2.19M2.75M114.00K133.00K1.81M7.69M11.26M11.11M4.73M5.91M11.11M11.79M13.74M9.20M14.20M29.10M22.00M18.68M33.66M84.31M69.43M86.48M11.99M18.81M
Free Cash Flow--------1.02M-9.99M9.47M6.73M26.11M383.00K15.48M26.05M78.80M62.37M58.80M52.07M107.31M37.47M75.41M67.85M109.96M186.44M181.72M
Dividends Paid------------1.45M9.54M11.93M23.85M35.78M35.78M35.78M35.78M17.89M17.89M47.70M53.67M53.67M59.63M
FCF to OCF--------15.36%-786.54%46.00%58.71%81.54%3.33%56.76%65.47%89.55%81.45%66.89%70.30%85.17%52.68%47.22%49.42%55.98%93.96%90.62%
Dividend Paid to FCF------------377.81%61.64%45.79%30.27%57.37%60.85%68.70%33.34%47.75%23.72%70.31%48.81%28.78%32.81%

Earnings

Report DateJun 30, 2007Sep 30, 2007Dec 31, 2007Apr 23, 2008Jul 15, 2008Oct 21, 2008Feb 16, 2009Apr 27, 2009Jul 15, 2009Oct 23, 2009Feb 12, 2010Apr 23, 2010Jul 16, 2010Oct 27, 2010Feb 15, 2011Apr 20, 2011Jul 15, 2011Oct 25, 2011Feb 14, 2012Apr 25, 2012Jul 18, 2012Oct 26, 2012Feb 14, 2013Apr 24, 2013Jul 17, 2013Oct 24, 2013Feb 12, 2014May 6, 2014Jul 18, 2014Nov 5, 2014Feb 12, 2015May 5, 2015Jul 17, 2015Nov 9, 2015Feb 12, 2016May 3, 2016Jul 15, 2016Oct 27, 2016Feb 7, 2017May 4, 2017Jul 18, 2017Oct 25, 2017Feb 9, 2018May 3, 2018Jul 17, 2018Oct 23, 2018Feb 7, 2019May 7, 2019Jul 16, 2019Oct 23, 2019Feb 5, 2020Apr 22, 2020Jul 16, 2020Oct 23, 2020Feb 4, 2021Apr 28, 2021Jul 20, 2021Oct 22, 2021Feb 4, 2022May 10, 2022Jul 20, 2022Oct 26, 2022Feb 8, 2023May 4, 2023Jul 20, 2023Oct 25, 2023Feb 7, 2024Apr 25, 2024Jul 19, 2024Oct 24, 2024Feb 6, 2025Apr 29, 2025Jul 18, 2025Nov 6, 2025Feb 4, 2026Apr 24, 2026Jul 17, 2026Oct 28, 2026
EPS Estimate----0.030.010.06-0.180.21----0.050.14-0.040.170.03-0.090.110.200.36--0.080.120.33-0.120.350.500.390.420.770.51-0.470.560.580.740.750.820.760.820.89-1.031.091.130.931.530.980.970.891.371.021.131.081.541.371.481.121.610.821.341.381.371.551.751.751.961.471.651.431.791.621.371.47
EPS Actual-0.120.160.120.050.060.140.820.020.040.220.88-0.200.34-0.091.560.000.090.210.310.110.130.160.17-0.06-0.010.360.540.250.380.200.490.340.211.020.640.420.710.640.751.060.810.320.730.800.910.701.241.151.270.721.020.851.140.561.201.191.301.091.671.611.560.441.350.811.461.092.111.261.621.301.721.741.581.311.790.941.37-
Surprise---266.67%500.00%133.33%--88.89%-80.95%---780.00%-164.29%--89.50%-47.06%600.00%-22.22%18.18%-20.00%-52.78%-87.50%200.00%63.64%-216.67%-42.86%-2.00%-12.82%-50.00%32.47%25.49%-51.06%14.29%29.31%43.24%8.00%-60.98%-3.95%-2.44%2.25%-20.39%5.50%12.39%-22.58%-33.33%-13.27%17.53%-37.08%-12.41%16.67%15.04%0.93%8.44%17.52%5.41%-60.71%-16.15%-1.22%8.96%-21.01%54.01%-18.71%-7.43%-25.71%-12.24%18.37%-4.24%-8.39%0.00%-41.98%0.00%-
Timing---Pre-marketPre-marketAfter-hours-Pre-marketPre-market---After-hours--Pre-marketAfter-hoursAfter-hours-After-hoursPre-marketPre-marketPre-market--Pre-marketAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap4.02B
Enterprise Value3.89B
Trailing P/E31.16
Forward P/E23.81
PEG Ratio0.00
Price / Sales5.44
Price / Book4.52
EPS5.41
Book Value37.14
Revenue (TTM)739.15M
Gross Profit (TTM)507.86M
EBITDA186.05M
Profit Margin17.47%
Operating Margin20.61%
Return on Equity15.11%
Return on Assets9.39%
Shares Outstanding23.85M
Shares Float19.50M
Beta0.98
Dividend Yield1.60%
Dividend Rate2.75
Payout Ratio50.83%

Dividends

20261×
2.75Apr 29, 2026
20251×
2.50May 7, 2025
20241×
2.25May 6, 2024
20231×
2.25May 8, 2023
20221×
2.00May 12, 2022
20211×
0.75Apr 30, 2021
20191×
1.50May 9, 2019
20181×
1.50May 7, 2018
20171×
1.50May 8, 2017
20161×
1.50May 6, 2016
20151×
1.00May 7, 2015
20141×
0.50May 8, 2014
20131×
0.40Apr 25, 2013
20121×
0.40May 3, 2012